Prevalence of Osteoporosis in Korean Prostate Cancer Patients Who is Receiving LHRH Agonist and/or Anti-androgen Agent
NCT01025479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 829
Last updated 2010-06-30
Summary
Prevalence rate of osteoporosis and it's actual management condition in Prostate cancer patients who takes LHRH antagonist and anti androgen
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Joon Woo Bahn, MD · AstraZeneca Korea
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-11-30
- Primary Completion
- 2010-03-31
- Completion
- 2010-03-31
Countries
- South Korea
Study Locations
More Related Trials
-
Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
NCT00003903 ·Status: COMPLETED ·Phase: NA
-
Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly
NCT00161252 ·Status: WITHDRAWN
-
Biomarkers of Bone Resorption in Metastatic Prostate Cancer
NCT01233557 ·Status: COMPLETED
-
Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer
NCT01819285 ·Status: COMPLETED ·Phase: PHASE3
-
Open Label Prostate Cancer Study
NCT01162395 ·Status: COMPLETED ·Phase: PHASE1
-
Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients
NCT06350825 ·Status: RECRUITING ·Phase: PHASE3
-
Retrospective Study to Assess Real-Life Use of The Long Acting GnRH Agonist as Prostate Cancer Treatment
NCT06217770 ·Status: COMPLETED
-
Sarcopenia in Older Patient With Prostate Cancer, Prevalence and Incidence After Androgen Deprivation Therapy
NCT04484246 ·Status: COMPLETED
-
Study of Blood and Tissue Samples From Patients Receiving Androgen Deprivation for Newly Diagnosed Prostate Cancer
NCT00967954 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer
NCT01071915 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer
NCT02440802 ·Status: UNKNOWN
-
Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
NCT00002924 ·Status: COMPLETED
-
Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients
NCT06500741 ·Status: COMPLETED
-
Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer
NCT00668083 ·Status: COMPLETED
-
Prostatic Cancer Versus Androgen Deficiency
NCT02235142 ·Status: COMPLETED ·Phase: NA
-
Non-Interventional Study to Establish Consensus on Management of Metastatic Hormone-Sensitive Prostate Cancer Patients
NCT06452212 ·Status: COMPLETED
-
Study to Assess the Feasibility of Stopping Prostate Cancer Treatment Early in Elderly Patients
NCT06824818 ·Status: RECRUITING ·Phase: NA
-
A Study of Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer
NCT01685983 ·Status: COMPLETED ·Phase: PHASE2
-
Towards Optimal Prescription of Chemotherapy in Prostate Cancer
NCT02512185 ·Status: COMPLETED
-
The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis
NCT00171639 ·Status: COMPLETED ·Phase: PHASE3
-
Surgery in Treating Patients With Prostate Cancer
NCT00002938 ·Status: COMPLETED ·Phase: PHASE2
-
Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer
NCT00816452 ·Status: COMPLETED
-
Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
NCT00052481 ·Status: COMPLETED
-
Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer
NCT03275181 ·Status: COMPLETED
-
Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation Therapy
NCT02946996 ·Status: TERMINATED ·Phase: PHASE2